JP2005239550A - Fatigue prophylactic and fatigue recovering agent - Google Patents

Fatigue prophylactic and fatigue recovering agent Download PDF

Info

Publication number
JP2005239550A
JP2005239550A JP2004047180A JP2004047180A JP2005239550A JP 2005239550 A JP2005239550 A JP 2005239550A JP 2004047180 A JP2004047180 A JP 2004047180A JP 2004047180 A JP2004047180 A JP 2004047180A JP 2005239550 A JP2005239550 A JP 2005239550A
Authority
JP
Japan
Prior art keywords
fatigue
yeast extract
yeast
prophylactic
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004047180A
Other languages
Japanese (ja)
Inventor
Masaaki Yasue
正明 安江
Osamu Nakakawanishi
修 中川西
Takeshi Tadano
武 只野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Breweries Ltd
Original Assignee
Asahi Breweries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Breweries Ltd filed Critical Asahi Breweries Ltd
Priority to JP2004047180A priority Critical patent/JP2005239550A/en
Publication of JP2005239550A publication Critical patent/JP2005239550A/en
Withdrawn legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain an excellent fatigue prophylactic and fatigue recovery agent for a body, excellently safe so as not to afford a production source for common infectious diseases of humans and animals and irrespective of simultaneous addition of an active ingredient other than a yeast extract or without the addition by using the yeast extract comprising natural nutrients formulated in a well-balanced state as an active ingredient, and to obtain a medicinal composition and to provide a food and drink comprising the same. <P>SOLUTION: The fatigue prophylactic or the fatigue ameliorating agent for the body comprises the yeast extract as the active ingredient. The medicinal composition and food and drink comprise the agent. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は酵母エキスを有効成分として含有する肉体の疲労予防・疲労回復剤に関する。 The present invention relates to a physical fatigue prevention / recovery agent containing yeast extract as an active ingredient.

従来から、肉体疲労の予防又は回復効果を目的として、種々の疲労回復飲食品もしくは医薬品が提供されてきた。例えば畜肉を酸、アルカリもしくは酵素処理して得たエキス類もしくはその画分(特許文献1、特許文献2参照)、ハーブ類の混合物(特許文献3参照)、ビタミンと医薬品の混合物等(特許文献4参照)があげられる。しかしながら、近年牛海綿状脳症等の問題から動物質のエキス・調味料が忌避される傾向があり、また天然噂好の高まりから人工的な混合物よりも天然に近い食材が好まれるようになってきた。 Conventionally, various fatigue-recovered foods and drinks or pharmaceuticals have been provided for the purpose of preventing or recovering physical fatigue. For example, extracts obtained by treating livestock meat with acid, alkali or enzyme or fractions thereof (see Patent Document 1 and Patent Document 2), mixtures of herbs (see Patent Document 3), mixtures of vitamins and pharmaceuticals, etc. (Patent Document) 4). However, in recent years, there has been a tendency for animal extracts and seasonings to be avoided due to problems such as bovine spongiform encephalopathy, and the growing popularity of natural rumors has led to the preference for ingredients that are closer to natural than artificial mixtures. It was.

ビール酵母やパン酵母を始めとするサッカロミセス酵母は、天然のビタミンB群、アミノ酸、ミネラル等をバランス良く含有しており、ビールやパンの製造に使われた後も有効活用されている。例えば乾燥酵母は我が国において70年以上にわたって医薬品、食品原料として使われており、栄養価と安全性の高い素材として認知されている。一方酵母から抽出したエキスも天然の調味料として様々な食品に使われているが、乾燥酵母と比較して人間の健康増進を目的とした用途には殆ど使われておらず、酵母エキスの肉体疲労予防・回復効果に関する報告は現時点では見あたらない。
特開2001−46021号公報 特開2002−51730号公報 特開2001−316279号公報 特開2003−119139号公報
Saccharomyces yeasts such as brewer's yeast and baker's yeast contain natural vitamin B groups, amino acids, minerals, etc. in a well-balanced manner, and are effectively used even after being used in the production of beer and bread. For example, dry yeast has been used in Japan as a pharmaceutical and food ingredient for over 70 years and is recognized as a highly nutritious and safe material. On the other hand, extract extracted from yeast is also used in various foods as a natural seasoning, but it is rarely used for the purpose of promoting human health compared to dry yeast. There are no reports on fatigue prevention and recovery effects at this time.
Japanese Patent Laid-Open No. 2001-46021 JP 2002-51730 A JP 2001-316279 A JP 2003-119139 A

従って本発明の目的は、天然の栄養素をバランスよく配合する酵母エキスを有効成分として使用し、人畜共通伝染病の発生源となり得ないなど安全性に優れ、酵母エキス以外の有効成分の同時添加・無添加に拘わらず、優れた肉体の疲労予防・疲労回復効果を発揮しうる疲労予防・疲労回復剤ならびに該剤を含有する医薬組成物および飲食品を提供することである。   Therefore, the purpose of the present invention is to use a yeast extract containing natural nutrients in a well-balanced manner as an active ingredient, which is excellent in safety such as being unable to be a source of zoonotic diseases, and simultaneously adding active ingredients other than yeast extract. It is intended to provide an anti-fatigue / fatigue-recovering agent capable of exhibiting excellent physical fatigue prevention / recovery effect, and a pharmaceutical composition and food / beverage product containing the agent, regardless of the addition.

本発明は上記目的を達成するためになされたもので、酵母より抽出したエキスが、これまで知られていなかったような生理活性を有することを動物実験により確認して本発明を完成するに至った。すなわち本発明は、酵母エキスを有効成分とする肉体疲労予防・改善機能を持つ飲食品もしくは医薬品を提供する。 The present invention has been made in order to achieve the above-mentioned object, and it has been confirmed by animal experiments that an extract extracted from yeast has physiological activity that has not been known so far, and the present invention has been completed. It was. That is, this invention provides the food-drinks or pharmaceutical which has the function of preventing and improving physical fatigue which uses yeast extract as an active ingredient.

本発明によれば、酵母エキスを原料として、肉体疲労予防・回復活性を有する物質を得ることができた。更にこれを、医薬品や飲食品の材料として容易に利用することができた。   According to the present invention, a substance having physical fatigue prevention / recovery activity can be obtained using yeast extract as a raw material. Furthermore, it could be easily used as a material for medicines and foods and drinks.

酵母エキスには市販品、自家製造品のどちらを使用しても良い。自家製造する場合には、エキスの原料には如何なる酵母を用いても良いが、好ましくはサッカロミセス属の酵母、特にビール酵母が推奨される。酵母エキスは、一般的には、酵母の自己消化、消化酵素処理、アルカリ、酸あるいは熱水処理、もしくは物理的損傷等により細胞壁の物質透過性を高め、水又は有機溶媒単独、あるいはこれらの混合物により、細胞内に含まれる可溶性成分を抽出することにより得られる。酵母エキスは、溶媒に溶解した状態で使用することもできるが、真空乾燥、凍結乾燥等により粉末化しても良い。粉末化に際して、適当な賦形剤を加えても差し支えない。 As the yeast extract, either a commercial product or a homemade product may be used. In the case of homemade production, any yeast may be used as a raw material for the extract, but yeast of the genus Saccharomyces, particularly beer yeast, is recommended. Yeast extract generally increases cell wall material permeability by yeast autolysis, digestive enzyme treatment, alkali, acid or hot water treatment, physical damage, etc., and water or an organic solvent alone or a mixture thereof. Thus, it is obtained by extracting soluble components contained in cells. The yeast extract can be used in a state dissolved in a solvent, but may be pulverized by vacuum drying, freeze drying or the like. An appropriate excipient may be added during powdering.

得られた酵母エキスは、経口の製品として医薬品として用いることができ、また食品素材と混合して飲食品とすることができる。性状としては固体状または液体状を呈し、医薬品としては経口剤として錠剤、カプセル剤、顆粒剤、シロップ剤等の剤型をとる。医薬品として人体に投与するときは、1回あたり1〜1000mg(乾燥重量)/k g体重の量、好ましくは1〜100mg(乾燥重量)/k g体重の量を、1日に1ないし数回経口投与する。 The obtained yeast extract can be used as a pharmaceutical product as an oral product, and can be mixed with a food material to make a food or drink. The property is solid or liquid, and the pharmaceutical is in the form of tablets, capsules, granules, syrups and the like as oral preparations. When administered to the human body as a pharmaceutical, 1 to 1000 mg (dry weight) / kg body weight, preferably 1 to 100 mg (dry weight) / kg body weight, orally once or several times a day To do.

飲食品とする場合、これと混合する食品素材は固形物(粉状、薄片状、塊状など)、半固形物(ゼリー状、水飴状など)、もしくは液状物等のいずれであっても良い。飲食品1gあたりの含有量は、1〜500mg(乾燥重量)であることが望ましい。本発明の酵母エキスを含有する医薬品及び飲食品は、肉体疲労の予防および回復効果を有するので、重労働後の疲労緩和、運動時のパフォーマンス向上など、様々な用途に応用が可能である。
以下、本発明を実施例によってさらに具体的に説明するが、本発明はこれに限定されるものではない。
In the case of a food or drink, the food material to be mixed may be a solid (powder, flake, lump, etc.), a semi-solid (jelly, syrup, etc.), or a liquid. The content per gram of food or drink is preferably 1 to 500 mg (dry weight). Since the pharmaceuticals and foods and drinks containing the yeast extract of the present invention have the effect of preventing and recovering from physical fatigue, they can be applied to various uses such as fatigue reduction after heavy work and performance improvement during exercise.
Hereinafter, the present invention will be described more specifically with reference to examples, but the present invention is not limited thereto.

(錠剤、カプセル剤)
酵母エキス 10.0g
乳糖 75.0g
ステアリン酸マグネシウム15.0g
合 計 100.0g

上記の各重量部を均一に混合し、常法に従って錠剤、カプセル剤とした。
(Tablets and capsules)
Yeast extract 10.0g
Lactose 75.0g
Magnesium stearate 15.0g
Total 100.0g

The above respective parts by weight were uniformly mixed, and tablets and capsules were prepared according to a conventional method.

(散剤、顆粒剤)
酵母エキス 20.0g
澱粉 30.0g
乳糖 50.0g
合 計 100.0g

上記の各重量部を均一に混合し、常法に従って散剤、頼粒剤とした。
(Powder, granule)
Yeast extract 20.0g
Starch 30.0g
Lactose 50.0g
Total 100.0g

Each said weight part was mixed uniformly, and it was set as the powder and the granule according to the conventional method.

(飴)
ショ糖 20.0g
水飴(75%固形分) 70.0g
水 9.4g
着色料 0.45g
香 料 0.05g
酵母エキス 0.1g
合 計 100.0g

上記の各重量部の各成分を用い、常法に従って飴とした。
(candy)
Sucrose 20.0g
Chickenpox (75% solids) 70.0g
9.4 g of water
Coloring material 0.45g
Perfume 0.05g
Yeast extract 0.1g
Total 100.0g

Using each component of each of the above parts by weight, it was made into a candy according to a conventional method.

(清涼飲料水)
果 糖 5.0g
クエン酸 0.2g
香 料 0.1g
色 素 0.15g
アスコルビン酸ナトリウム 0.05g
酵母エキス 0.05g
水 94.45g
合 計 100.0g

上記の各重量部の各成分を用い、常法に従って清涼飲料水とした。
(Soft drink)
Fructose 5.0g
Citric acid 0.2g
Fragrance 0.1g
0.15 g of color
Sodium ascorbate 0.05g
Yeast extract 0.05g
94.45 g of water
Total 100.0g

Using each component of each of the above-mentioned parts by weight, a soft drink was prepared according to a conventional method.

(ジュース)
濃縮ミカン果汁 15.0g
果 糖 5.0g
クエン酸 0.2g
香 料 0.1g
色 素 0.15g
アスコルビン酸ナトリウム 0.05g
酵母エキス 0.05g
水 79.45g
合 計 100.0g

上記の各重量部の各成分を用い、常法に従ってジュースとした。
(juice)
Concentrated tangerine juice 15.0 g
Fructose 5.0g
Citric acid 0.2g
Fragrance 0.1g
0.15 g of color
Sodium ascorbate 0.05g
Yeast extract 0.05g
79.45 g of water
Total 100.0g

Using each component of the above-mentioned parts by weight, juice was prepared according to a conventional method.

(クッキー)
薄力粉 32.0g
全 卵 16.0g
バター 16.0g
砂 糖 25.0g
水 10.7g
ベーキングパウダー 0.2g
酵母エキス 0.1g
合 計 100.0g

上記の各重量部の各成分を用い、常法に従ってクッキーとした。
(cookie)
Soft flour 32.0g
Whole egg 16.0g
16.0g butter
Sand sugar 25.0g
10.7g of water
Baking powder 0.2g
Yeast extract 0.1g
Total 100.0g

Using each component of the above-mentioned parts by weight, a cookie was prepared according to a conventional method.

(酵母エキスの抗疲労作用)
体重25〜28gの雄性ddYマウスを一群 10匹から成る5試験群に分け、それぞれに水、0.004%の酵母エキス水溶液、0.02%の酵母エキス水溶液、0.1%の酵母エキス水溶液、および0.5%の酵母エキス水溶液を飲み水として10日間自由摂取させた。マウスを回転カゴに入れて3時間強制歩行運動(回転カゴの直径37cm、2回転/分)をさせた後、1.5時間にわたってAnime x装置により自発行動量を測定した。酵母エキスの投与により強制運動負荷後の自発行動量が用量依存的かつ有意に増加し、0.1%および0.5%の酵母エキス投与群においては、強制運動負荷による自発行動量の低下が殆ど観察されなかった。
(Anti-fatigue action of yeast extract)
Male ddY mice weighing 25-28 g are divided into 5 test groups consisting of 10 animals, each with water, 0.004% yeast extract aqueous solution, 0.02% yeast extract aqueous solution, 0.1% yeast extract aqueous solution, and 0.5% yeast. The extract aqueous solution was ingested freely as drinking water for 10 days. The mouse was placed in a rotating basket and subjected to a forced walking movement (diameter of the rotating basket of 37 cm, 2 rotations / minute) for 3 hours, and then the amount of self-issued movement was measured with the Anime x apparatus for 1.5 hours. Administration of yeast extract significantly increased the amount of spontaneous movement after forced exercise, and the decrease in spontaneous movement due to forced exercise was almost observed in the 0.1% and 0.5% yeast extract administration groups. Was not.

酵母エキス以外の有効成分の同時添加・無添加に拘わらず、優れた肉体の疲労予防・疲労回復効果を発揮しうる疲労予防・疲労回復剤ならびに該剤を含有する医薬組成物および飲食品を提供することができる。 Provided are a fatigue preventive / fatigue recovering agent capable of exerting excellent fatigue prevention / fatigue recovery effects regardless of simultaneous addition / non-addition of active ingredients other than yeast extract, and pharmaceutical compositions and food / beverage products containing the agent can do.

酵母エキスが強制運動負荷後の自発行動量に及ぼす影響を示す図である。*:水投与群に対してp<0.05It is a figure which shows the influence which a yeast extract exerts on the self-issue amount after a forced exercise load. *: P <0.05 for the water-administered group

Claims (6)

酵母エキスを有効成分として含有することを特徴とする肉体疲労予防・疲労回復剤。 A physical fatigue prevention / recovery agent comprising a yeast extract as an active ingredient. 酵母エキスが、ビール酵母由来であることを特徴とする請求項1記載の肉体疲労予防・疲労回復剤。 The body fatigue prevention / fatigue recovery agent according to claim 1, wherein the yeast extract is derived from brewer's yeast. 酵母エキスが、酵母を自己消化して得られたエキスであることを特徴とする請求項1又は2記載の肉体疲労予防・疲労回復剤。 The agent for preventing or recovering from physical fatigue according to claim 1 or 2, wherein the yeast extract is an extract obtained by self-digesting yeast. 酵母エキスが、全窒素含有量10〜15%、且つビタミンB1含有量100μg/g以上であることを特徴とする請求項1ないし3の何れか1項記載の肉体疲労予防・疲労回復剤。 The body fatigue prevention / recovery agent according to any one of claims 1 to 3, wherein the yeast extract has a total nitrogen content of 10 to 15% and a vitamin B1 content of 100 µg / g or more. 請求項1ないし4の何れか1項記載の肉体疲労予防・疲労回復剤を含有する疲労予防・疲労回復用医薬組成物。 A pharmaceutical composition for fatigue prevention / recovery comprising the physical fatigue prevention / recovery agent according to any one of claims 1 to 4. 請求項1ないし4の何れか1項記載の肉体疲労予防・疲労回復剤を含有する疲労予防・疲労回復用飲食品。 5. A food and drink for fatigue prevention / fatigue recovery comprising the physical fatigue prevention / fatigue recovery agent according to any one of claims 1 to 4.
JP2004047180A 2004-02-24 2004-02-24 Fatigue prophylactic and fatigue recovering agent Withdrawn JP2005239550A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004047180A JP2005239550A (en) 2004-02-24 2004-02-24 Fatigue prophylactic and fatigue recovering agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004047180A JP2005239550A (en) 2004-02-24 2004-02-24 Fatigue prophylactic and fatigue recovering agent

Publications (1)

Publication Number Publication Date
JP2005239550A true JP2005239550A (en) 2005-09-08

Family

ID=35021672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004047180A Withdrawn JP2005239550A (en) 2004-02-24 2004-02-24 Fatigue prophylactic and fatigue recovering agent

Country Status (1)

Country Link
JP (1) JP2005239550A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009107962A (en) * 2007-10-29 2009-05-21 Asahi Breweries Ltd Yeast extract-containing composition
KR20140079389A (en) * 2011-10-06 2014-06-26 라이온 가부시키가이샤 Agent for improving quality of sleep
CN105146666A (en) * 2015-08-11 2015-12-16 广东江门生物技术开发中心有限公司 Solid beverage capable of complementing B vitamins and preparation method of solid beverage
JP2021020881A (en) * 2019-07-30 2021-02-18 三菱商事ライフサイエンス株式会社 Fatigue recovery agent

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009107962A (en) * 2007-10-29 2009-05-21 Asahi Breweries Ltd Yeast extract-containing composition
KR20140079389A (en) * 2011-10-06 2014-06-26 라이온 가부시키가이샤 Agent for improving quality of sleep
KR101961974B1 (en) 2011-10-06 2019-03-25 라이온 가부시키가이샤 Agent for improving quality of sleep
CN105146666A (en) * 2015-08-11 2015-12-16 广东江门生物技术开发中心有限公司 Solid beverage capable of complementing B vitamins and preparation method of solid beverage
JP2021020881A (en) * 2019-07-30 2021-02-18 三菱商事ライフサイエンス株式会社 Fatigue recovery agent

Similar Documents

Publication Publication Date Title
CA2854281C (en) A muscle atrophy inhibitor
CN114502184A (en) Pharmaceutical and food compositions for the prevention and treatment of coronavirus infection comprising Elaeagnus dulcis extract
US20120214755A1 (en) Methods of producing and using nutritional and pharmaceutical compositions that include one or more active substances
JP6086953B2 (en) AMPK activator
KR100887854B1 (en) Preventives or Remedies for Arthritis
JP5224680B2 (en) Anti-fatigue
WO2015137387A1 (en) Muscle enhancing drug
JP2019034896A (en) Oral composition
JP7231898B2 (en) sleep quality improver
JP6787595B2 (en) Blood flow improver, royal jelly composition and method for producing royal jelly composition
JP2005239550A (en) Fatigue prophylactic and fatigue recovering agent
KR20200023576A (en) Composition for improving hepatic function comprising extract of fermented Protaetia brevitarsis larva as effective component
KR101713309B1 (en) Food composition or pharmaceutical composition for immune activity with the extract of Pinus Koraiensis peel
JP2019034920A (en) PDE5 activity inhibitor
WO2008023425A1 (en) Composition for amelioration of skin condition
JP6981641B2 (en) PDE5 activity inhibitor
JP2006316006A (en) Chitosan compounded composition and food
JP2009084191A (en) Pharmaceutical composition for inhibiting appetite
JP2017088549A (en) Endurance enhancers
JP7086517B2 (en) Composition for improving intestinal flora containing powder containing eggshell membrane as an active ingredient
JP2005022994A (en) Hypoglycemic composition
JP6829487B2 (en) Anti-fatigue
JP7058407B2 (en) Oral composition
JP2006241020A (en) Immune system activating agent
JP6537887B2 (en) Vertigo improving agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070123

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20091027